在遺傳學，'''超級強化子'''（Super-enhancer）是哺乳類基因體中包含多個[[強化子|強化子]]的區域，可以結合許多[[轉錄因子|轉錄因子]]來啟動決定細胞分化結果之基因的[[轉錄|轉錄]]。<ref name="Whyte2013">{{cite journal|title=Master transcription factors and mediator establish super-enhancers at key cell identity genes|date=April 2013|journal=Cell|issue=2|doi=10.1016/j.cell.2013.03.035|volume=153|pages=307–19|pmc=3653129|pmid=23582322|vauthors=Whyte WA, Orlando DA, Hnisz D, Abraham BJ, Lin CY, Kagey MH, Rahl PB, Lee TI, Young RA}}</ref><ref name="Parker2013">{{cite journal|title=Chromatin stretch enhancer states drive cell-specific gene regulation and harbor human disease risk variants|date=October 2013|journal=Proceedings of the National Academy of Sciences of the United States of America|issue=44|doi=10.1073/pnas.1317023110|volume=110|pages=17921–6|pmc=3816444|pmid=24127591|vauthors=Parker SC, Stitzel ML, Taylor DL, Orozco JM, Erdos MR, Akiyama JA, van Bueren KL, Chines PS, Narisu N, Black BL, Visel A, Pennacchio LA, Collins FS}}</ref><ref name="Hnisz2013">{{cite journal|title=Super-enhancers in the control of cell identity and disease|date=November 2013|journal=Cell|issue=4|doi=10.1016/j.cell.2013.09.053|volume=155|pages=934–47|pmc=3841062|pmid=24119843|vauthors=Hnisz D, Abraham BJ, Lee TI, Lau A, Saint-André V, Sigova AA, Hoke HA, Young RA}}</ref>由於超級強化子經常出現於控制、定義細胞身份基因的附近，因此它們也可被用來快速定位基因組中調控細胞身份的關鍵位點。<ref name="Hnisz2013" /><ref name="Saint-André2016">{{cite journal|title=Models of human core transcriptional regulatory circuitries|date=March 2016|journal=Genome Research|issue=3|doi=10.1101/gr.197590.115|volume=26|pages=385–96|pmc=4772020|pmid=26843070|vauthors=Saint-André V, Federation AJ, Lin CY, Abraham BJ, Reddy J, Lee TI, Bradner JE, Young RA}}</ref>

超級強化子會與許多與轉錄調控相關的蛋白結合，並常用於調控高表現量的基因表現<ref name="Whyte2013" /><ref name="Kwiatkowski2014">{{cite journal|title=Targeting transcription regulation in cancer with a covalent CDK7 inhibitor|url=https://dash.harvard.edu/bitstream/handle/1/13890593/4244910.pdf?sequence=1|date=July 2014|journal=Nature|issue=7511|doi=10.1038/nature13393|volume=511|pages=616–20|pmc=4244910|pmid=25043025|display-authors=6|vauthors=Kwiatkowski N, Zhang T, Rahl PB, Abraham BJ, Reddy J, Ficarro SB, Dastur A, Amzallag A, Ramaswamy S, Tesar B, Jenkins CE, Hannett NM, McMillin D, Sanda T, Sim T, Kim ND, Look T, Mitsiades CS, Weng AP, Brown JR, Benes CH, Marto JA, Young RA, Gray NS}}</ref><ref name="Lovén2013">{{cite journal|title=Selective inhibition of tumor oncogenes by disruption of super-enhancers|date=April 2013|journal=Cell|issue=2|doi=10.1016/j.cell.2013.03.036|volume=153|pages=320–34|pmc=3760967|pmid=23582323|vauthors=Lovén J, Hoke HA, Lin CY, Lau A, Orlando DA, Vakoc CR, Bradner JE, Lee TI, Young RA}}</ref><ref name="Dowen2014">{{cite journal|title=Control of cell identity genes occurs in insulated neighborhoods in mammalian chromosomes|date=October 2014|journal=Cell|issue=2|doi=10.1016/j.cell.2014.09.030|volume=159|pages=374–87|pmc=4197132|pmid=25303531|vauthors=Dowen JM, Fan ZP, Hnisz D, Ren G, Abraham BJ, Zhang LN, Weintraub AS, Schuijers J, Lee TI, Zhao K, Young RA}}</ref>與超級強化子相關的基因表現會特別對擾動敏感，可能控制細胞狀態的轉換，這也導致由超級強化子調控的基因常對影響轉錄的小分子較為敏感。<ref name="Whyte2013" /><ref name="Kwiatkowski2014" /><ref name="Lovén2013" /><ref name="Christensen2014">{{cite journal|title=Targeting transcriptional addictions in small cell lung cancer with a covalent CDK7 inhibitor|date=December 2014|journal=Cancer Cell|issue=6|doi=10.1016/j.ccell.2014.10.019|volume=26|pages=909–22|pmc=4261156|pmid=25490451|display-authors=6|vauthors=Christensen CL, Kwiatkowski N, Abraham BJ, Carretero J, Al-Shahrour F, Zhang T, Chipumuro E, Herter-Sprie GS, Akbay EA, Altabef A, Zhang J, Shimamura T, Capelletti M, Reibel JB, Cavanaugh JD, Gao P, Liu Y, Michaelsen SR, Poulsen HS, Aref AR, Barbie DA, Bradner JE, George RE, Gray NS, Young RA, Wong KK}}</ref><ref name="Chipumuro2014">{{cite journal|title=CDK7 inhibition suppresses super-enhancer-linked oncogenic transcription in MYCN-driven cancer|date=November 2014|journal=Cell|issue=5|doi=10.1016/j.cell.2014.10.024|volume=159|pages=1126–39|pmc=4243043|pmid=25416950|vauthors=Chipumuro E, Marco E, Christensen CL, Kwiatkowski N, Zhang T, Hatheway CM, Abraham BJ, Sharma B, Yeung C, Altabef A, Perez-Atayde A, Wong KK, Yuan GC, Gray NS, Young RA, George RE}}</ref>

== 歷史 ==
有關強化子對轉錄調控的研究始於1980年代。<ref>{{cite journal|title=Expression of a beta-globin gene is enhanced by remote SV40 DNA sequences|date=December 1981|journal=Cell|issue=2 Pt 1|doi=10.1016/0092-8674(81)90413-x|volume=27|pages=299–308|pmid=6277502|vauthors=Banerji J, Rusconi S, Schaffner W}}</ref><ref>{{cite journal|title=In vivo sequence requirements of the SV40 early promotor region|date=March 1981|journal=Nature|issue=5804|doi=10.1038/290304a0|volume=290|pages=304–10|pmid=6259538|vauthors=Benoist C, Chambon P}}</ref><ref>{{cite journal|title=Simian virus 40 tandem repeated sequences as an element of the early promoter|date=February 1981|journal=Proceedings of the National Academy of Sciences of the United States of America|issue=2|doi=10.1073/pnas.78.2.943|volume=78|pages=943–7|pmc=319921|pmid=6262784|vauthors=Gruss P, Dhar R, Khoury G}}</ref><ref>{{cite journal|title=Control of globin gene transcription|date=1990|journal=Annual Review of Cell Biology|doi=10.1146/annurev.cb.06.110190.000523|volume=6|pages=95–124|pmid=2275826|vauthors=Evans T, Felsenfeld G, Reitman M}}</ref><ref>{{cite journal|title=Resistance to intracellular infections: comparative genomic analysis of Nramp|date=June 1996|journal=Trends in Genetics|issue=6|doi=10.1016/0168-9525(96)30042-5|volume=12|pages=201–4|pmid=8928221|vauthors=Cellier M, Belouchi A, Gros P}}</ref> 不久後發現了一些大型或多單元的轉錄調控區域，包含[[基因座控制區|基因座控制區]]、成簇的開放調控元件與轉錄起始的平台等。<ref>{{cite journal|title=Locus control regions|date=November 2002|journal=Blood|issue=9|doi=10.1182/blood-2002-04-1104|volume=100|pages=3077–86|pmc=2811695|pmid=12384402|vauthors=Li Q, Peterson KR, Fang X, Stamatoyannopoulos G}}</ref><ref>{{cite journal|title=Position-independent, high-level expression of the human beta-globin gene in transgenic mice|date=December 1987|journal=Cell|issue=6|doi=10.1016/0092-8674(87)90584-8|volume=51|pages=975–85|pmid=3690667|vauthors=Grosveld F, van Assendelft GB, Greaves DR, Kollias G}}</ref><ref>{{cite journal|title=A map of open chromatin in human pancreatic islets|date=March 2010|journal=Nature Genetics|issue=3|doi=10.1038/ng.530|volume=42|pages=255–9|pmc=2828505|pmid=20118932|display-authors=6|vauthors=Gaulton KJ, Nammo T, Pasquali L, Simon JM, Giresi PG, Fogarty MP, Panhuis TM, Mieczkowski P, Secchi A, Bosco D, Berney T, Montanya E, Mohlke KL, Lieb JD, Ferrer J}}</ref><ref name="Koch2011">{{cite journal|title=Transcription initiation platforms and GTF recruitment at tissue-specific enhancers and promoters|date=August 2011|journal=Nature Structural & Molecular Biology|issue=8|doi=10.1038/nsmb.2085|volume=18|pages=956–63|pmid=21765417|vauthors=Koch F, Fenouil R, Gut M, Cauchy P, Albert TK, Zacarias-Cabeza J, Spicuglia S, de la Chapelle AL, Heidemann M, Hintermair C, Eick D, Gut I, Ferrier P, Andrau JC}}</ref>近期的研究結果表明，這些不同類別的調控單元可能都屬於超級強化子。<ref name="Pott2015">{{cite journal|title=What are super-enhancers?|date=January 2015|journal=Nature Genetics|issue=1|doi=10.1038/ng.3167|volume=47|pages=8–12|pmid=25547603|vauthors=Pott S, Lieb JD}}</ref>

2013年，兩組研究團隊分別在基因組中對決定細胞分化種類重要的位點附近發現了大型強化子，其中{{tsl|en|Richard A. Young|理查德·楊}}的團隊發現了超級強化子，[[法蘭西斯·柯林斯|法蘭西斯·柯林斯]]的團隊則發現了延伸強化子（{{lang|en|stretch enhancers}}）。<ref name="Whyte20132">{{cite journal|title=Master transcription factors and mediator establish super-enhancers at key cell identity genes|date=April 2013|journal=Cell|issue=2|doi=10.1016/j.cell.2013.03.035|volume=153|pages=307–19|pmc=3653129|pmid=23582322|vauthors=Whyte WA, Orlando DA, Hnisz D, Abraham BJ, Lin CY, Kagey MH, Rahl PB, Lee TI, Young RA}}</ref><ref name="Parker20132">{{cite journal|title=Chromatin stretch enhancer states drive cell-specific gene regulation and harbor human disease risk variants|date=October 2013|journal=Proceedings of the National Academy of Sciences of the United States of America|issue=44|doi=10.1073/pnas.1317023110|volume=110|pages=17921–6|pmc=3816444|pmid=24127591|vauthors=Parker SC, Stitzel ML, Taylor DL, Orozco JM, Erdos MR, Akiyama JA, van Bueren KL, Chines PS, Narisu N, Black BL, Visel A, Pennacchio LA, Collins FS}}</ref>超級強化子及延伸強化子皆為成簇的強化子，控制了細胞中特定的基因表現，可能是極為相似的元件。<ref name="Parker20132" /><ref name="Hnisz2015">{{cite journal|title=Convergence of developmental and oncogenic signaling pathways at transcriptional super-enhancers|date=April 2015|journal=Molecular Cell|issue=2|doi=10.1016/j.molcel.2015.02.014|volume=58|pages=362–70|pmc=4402134|pmid=25801169|vauthors=Hnisz D, Schuijers J, Lin CY, Weintraub AS, Abraham BJ, Lee TI, Bradner JE, Young RA}}</ref>

根據目前定義，「超級強化子」一詞由美國遺傳學家理查德·楊的團隊定義，用來描述在小鼠的[[胚胎幹細胞|胚胎幹細胞]]中發現<ref name="Whyte20132" />、長度較長、且能控制影響幹細胞分化結果之基因（包括[[Oct4|Oct-4]]、[[Sox2|Sox2]]、[[同源框蛋白質NANOG|Nanog]]、{{Translink|en|KLF4}} 以及 Esrrb等）表現的特定元件。干擾調控這些基因的超級強化子會嚴重影響這些基因的表現。<ref name="Hnisz2015" />超級強化子已經在一些小鼠與人類組織的基因組中，負責控制細胞分化結果之基因附近被發現。<ref name="Parker20132" /><ref name="Hnisz20132">{{cite journal|title=Super-enhancers in the control of cell identity and disease|date=November 2013|journal=Cell|issue=4|doi=10.1016/j.cell.2013.09.053|volume=155|pages=934–47|pmc=3841062|pmid=24119843|vauthors=Hnisz D, Abraham BJ, Lee TI, Lau A, Saint-André V, Sigova AA, Hoke HA, Young RA}}</ref><ref name="DiMicco2014">{{cite journal|title=Control of embryonic stem cell identity by BRD4-dependent transcriptional elongation of super-enhancer-associated pluripotency genes|date=October 2014|journal=Cell Reports|issue=1|doi=10.1016/j.celrep.2014.08.055|volume=9|pages=234–47|pmc=4317728|pmid=25263550|display-authors=6|vauthors=Di Micco R, Fontanals-Cirera B, Low V, Ntziachristos P, Yuen SK, Lovell CD, Dolgalev I, Yonekubo Y, Zhang G, Rusinova E, Gerona-Navarro G, Cañamero M, Ohlmeyer M, Aifantis I, Zhou MM, Tsirigos A, Hernando E}}</ref><ref name="Ji2016">{{cite journal|title=3D Chromosome Regulatory Landscape of Human Pluripotent Cells|date=February 2016|journal=Cell Stem Cell|issue=2|doi=10.1016/j.stem.2015.11.007|volume=18|pages=262–75|pmid=26686465|vauthors=Ji X, Dadon DB, Powell BE, Fan ZP, Borges-Rivera D, Shachar S, Weintraub AS, Hnisz D, Pegoraro G, Lee TI, Misteli T, Jaenisch R, Young RA}}</ref><ref name="Tsankov2015">{{cite journal|title=Transcription factor binding dynamics during human ES cell differentiation|date=February 2015|journal=Nature|issue=7539|doi=10.1038/nature14233|volume=518|pages=344–9|pmc=4499331|pmid=25693565|vauthors=Tsankov AM, Gu H, Akopian V, Ziller MJ, Donaghey J, Amit I, Gnirke A, Meissner A}}</ref><ref name="Fang2015">{{cite journal|title=Transcription factor co-occupied regions in the murine genome constitute T-helper-cell subtype-specific enhancers|date=November 2015|journal=European Journal of Immunology|issue=11|doi=10.1002/eji.201545713|volume=45|pages=3150–7|pmid=26300430|vauthors=Fang Z, Hecklau K, Gross F, Bachmann I, Venzke M, Karl M, Schuchhardt J, Radbruch A, Herzel H, Baumgrass R}}</ref><ref name="Vahedi2015">{{cite journal|title=Super-enhancers delineate disease-associated regulatory nodes in T cells|date=April 2015|journal=Nature|issue=7548|doi=10.1038/nature14154|volume=520|pages=558–62|pmc=4409450|pmid=25686607|vauthors=Vahedi G, Kanno Y, Furumoto Y, Jiang K, Parker SC, Erdos MR, Davis SR, Roychoudhuri R, Restifo NP, Gadina M, Tang Z, Ruan Y, Collins FS, Sartorelli V, O'Shea JJ}}</ref><ref name="Koues2015">{{cite journal|title=Enhancer sequence variants and transcription-factor deregulation synergize to construct pathogenic regulatory circuits in B-cell lymphoma|date=January 2015|journal=Immunity|issue=1|doi=10.1016/j.immuni.2014.12.021|volume=42|pages=186–98|pmc=4302272|pmid=25607463|vauthors=Koues OI, Kowalewski RA, Chang LW, Pyfrom SC, Schmidt JA, Luo H, Sandoval LE, Hughes TB, Bednarski JJ, Cashen AF, Payton JE, Oltz EM}}</ref><ref name="Adam2015">{{cite journal|title=Pioneer factors govern super-enhancer dynamics in stem cell plasticity and lineage choice|date=May 2015|journal=Nature|issue=7552|doi=10.1038/nature14289|volume=521|pages=366–70|pmc=4482136|pmid=25799994|vauthors=Adam RC, Yang H, Rockowitz S, Larsen SB, Nikolova M, Oristian DS, Polak L, Kadaja M, Asare A, Zheng D, Fuchs E}}</ref><ref name="Siersbæk2014a">{{cite journal|title=Molecular architecture of transcription factor hotspots in early adipogenesis|date=June 2014|journal=Cell Reports|issue=5|doi=10.1016/j.celrep.2014.04.043|volume=7|pages=1434–42|pmid=24857666|vauthors=Siersbæk R, Baek S, Rabiee A, Nielsen R, Traynor S, Clark N, Sandelin A, Jensen ON, Sung MH, Hager GL, Mandrup S}}</ref><ref name="Siersbæk2014b">{{cite journal|title=Transcription factor cooperativity in early adipogenic hotspots and super-enhancers|date=June 2014|journal=Cell Reports|issue=5|doi=10.1016/j.celrep.2014.04.042|volume=7|pages=1443–55|pmid=24857652|vauthors=Siersbæk R, Rabiee A, Nielsen R, Sidoli S, Traynor S, Loft A, La Cour Poulsen L, Rogowska-Wrzesinska A, Jensen ON, Mandrup S}}</ref><ref name="Harms2014">{{cite journal|title=Prdm16 is required for the maintenance of brown adipocyte identity and function in adult mice|date=April 2014|journal=Cell Metabolism|issue=4|doi=10.1016/j.cmet.2014.03.007|volume=19|pages=593–604|pmc=4012340|pmid=24703692|display-authors=6|vauthors=Harms MJ, Ishibashi J, Wang W, Lim HW, Goyama S, Sato T, Kurokawa M, Won KJ, Seale P}}</ref><ref name="Loft2015">{{cite journal|title=Browning of human adipocytes requires KLF11 and reprogramming of PPARγ superenhancers|date=January 2015|journal=Genes & Development|issue=1|doi=10.1101/gad.250829.114|volume=29|pages=7–22|pmc=4281566|pmid=25504365|vauthors=Loft A, Forss I, Siersbæk MS, Schmidt SF, Larsen AS, Madsen JG, Pisani DF, Nielsen R, Aagaard MM, Mathison A, Neville MJ, Urrutia R, Karpe F, Amri EZ, Mandrup S}}</ref><ref name="Pasquali2014">{{cite journal|title=Pancreatic islet enhancer clusters enriched in type 2 diabetes risk-associated variants|date=February 2014|journal=Nature Genetics|issue=2|doi=10.1038/ng.2870|volume=46|pages=136–43|pmc=3935450|pmid=24413736|display-authors=6|vauthors=Pasquali L, Gaulton KJ, Rodríguez-Seguí SA, Mularoni L, Miguel-Escalada I, Akerman I, Tena JJ, Morán I, Gómez-Marín C, van de Bunt M, Ponsa-Cobas J, Castro N, Nammo T, Cebola I, García-Hurtado J, Maestro MA, Pattou F, Piemonti L, Berney T, Gloyn AL, Ravassard P, Gómez-Skarmeta JL, Müller F, McCarthy MI, Ferrer J}}</ref><ref name="Liu2015">{{cite journal|title=The transcription factors SOX9 and SOX5/SOX6 cooperate genome-wide through super-enhancers to drive chondrogenesis|date=September 2015|journal=Nucleic Acids Research|issue=17|doi=10.1093/nar/gkv688|volume=43|pages=8183–203|pmc=4787819|pmid=26150426|vauthors=Liu CF, Lefebvre V}}</ref><ref name="Ohba2015">{{cite journal|title=Distinct Transcriptional Programs Underlie Sox9 Regulation of the Mammalian Chondrocyte|date=July 2015|journal=Cell Reports|issue=2|doi=10.1016/j.celrep.2015.06.013|volume=12|pages=229–43|pmc=4504750|pmid=26146088|vauthors=Ohba S, He X, Hojo H, McMahon AP}}</ref><ref name="Kaikkonen2014">{{cite journal|title=Control of VEGF-A transcriptional programs by pausing and genomic compartmentalization|date=November 2014|journal=Nucleic Acids Research|issue=20|doi=10.1093/nar/gku1036|volume=42|pages=12570–84|pmc=4227755|pmid=25352550|vauthors=Kaikkonen MU, Niskanen H, Romanoski CE, Kansanen E, Kivelä AM, Laitalainen J, Heinz S, Benner C, Glass CK, Ylä-Herttuala S}}</ref><ref name="Gosselin2014">{{cite journal|title=Environment drives selection and function of enhancers controlling tissue-specific macrophage identities|date=December 2014|journal=Cell|issue=6|doi=10.1016/j.cell.2014.11.023|volume=159|pages=1327–40|pmc=4364385|pmid=25480297|vauthors=Gosselin D, Link VM, Romanoski CE, Fonseca GJ, Eichenfield DZ, Spann NJ, Stender JD, Chun HB, Garner H, Geissmann F, Glass CK}}</ref><ref name="Sun2015">{{cite journal|title=Identification of in vivo DNA-binding mechanisms of Pax6 and reconstruction of Pax6-dependent gene regulatory networks during forebrain and lens development|date=August 2015|journal=Nucleic Acids Research|issue=14|doi=10.1093/nar/gkv589|volume=43|pages=6827–46|pmc=4538810|pmid=26138486|vauthors=Sun J, Rockowitz S, Xie Q, Ashery-Padan R, Zheng D, Cvekl A}}</ref>

== 功能 ==

== 相關疾病 ==

== 偵測方式 ==
超級強化子的偵測方式，大多是以[[染色质免疫沉淀-测序|染色质免疫沉淀-测序]]偵測主要轉錄因子、{{link-en|仲介體|Mediator (coactivator)}}與{{tsl|en|BRD4|BRD4蛋白}}等{{tsl|en|Transcription coregulator|共同因子}}或{{tsl|en|H3K27ac|H3K27ac核小體}}在基因組中的結合位點，其中以H3K27ac核小體最為常用。<ref name=Whyte2013 /><ref name=Hnisz2013 /><ref name= "Lovén2013" /><ref name="Wei2016">{{cite journal | vauthors = Wei Y, Zhang S, Shang S, Zhang B, Li S, Wang X, Wang F, Su J, Wu Q, Liu H, Zhang Y | title = SEA: a super-enhancer archive | journal = Nucleic Acids Research | volume = 44 | issue = D1 | pages = D172-9 | date = January 2016 | pmid = 26578594 | pmc = 4702879 | doi = 10.1093/nar/gkv1243 }}</ref><ref name="Khan2016">{{cite journal | vauthors = Khan A, Zhang X | title = dbSUPER: a database of super-enhancers in mouse and human genome | journal = Nucleic Acids Research | volume = 44 | issue = D1 | pages = D164-71 | date = January 2016 | pmid = 26438538 | pmc = 4702767 | doi = 10.1093/nar/gkv1002 }}</ref><ref name="Creyghton2010">{{cite journal | vauthors = Creyghton MP, Cheng AW, Welstead GG, Kooistra T, Carey BW, Steine EJ, Hanna J, Lodato MA, Frampton GM, Sharp PA, Boyer LA, Young RA, Jaenisch R | title = Histone H3K27ac separates active from poised enhancers and predicts developmental state | journal = Proceedings of the National Academy of Sciences of the United States of America | volume = 107 | issue = 50 | pages = 21931–6 | date = December 2010 | pmid = 21106759 | pmc = 3003124 | doi = 10.1073/pnas.1016071107 }}</ref>理察·楊的團隊開發了一個稱為“ROSE”（Rank Ordering of Super-Enhancers）的程式，可用於從染色質免疫沉澱定序的結果中偵測超級強化子，這個程式可依據超級強化子中某些標記的含量比一般強化子更多的特性，判定數個已知的強化子是否組成超級強化子，而用以判定的間距標準可依不同情況調整。<ref name=Whyte2013 />

== 參考資料 ==
{{Reflist}}

[[Category:基因表現|Category:基因表現]]